Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction

Neurobiology of Aging

Volumn 26, Issue 6, 2005, Pages 813-823

  Thilakawardhana, Shanaka ^a   Everett, David M ^b   Murdock, Paul R ^b   Dingwall, Colin ^b   Owen, James S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; Gene expression; Nitric oxide

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI; SCAVENGER RECEPTOR BII; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN CELL; CELL LINE; GLIOMA CELL; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 13844256586     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.08.004     Document Type: Article

References (64)

1. S. Acton, A. Rigotti, K.T. Landschulz, S. Xu, H.H. Hobbs, and M. Krieger Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 271 1996 518 520
2. K.R. Bales, J.C. Dodart, R.B. DeMattos, D.M. Holtzman, and S.M. Paul Apolipoprotein E, amyloid, and Alzheimer disease Mol Intervent 2 2002 363 375
3. R.S. Bedlack, W.J. Strittmatter, and J.C. Morgenlander Apolipoprotein E and neuromuscular disease: a critical review of the literature Arch Neurol 57 2000 1561 1565
4. U. Beffert, M. Danik, P. Krzywkowski, C. Ramassamy, F. Berrada, and J. Poirier The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease Brain Res Rev 27 1998 119 142
5. U. Beffert, P.C. Stolt, and J. Herz Functions of lipoprotein receptors in neurons J Lipid Res 45 2004 403 409
6. S. Bellosta, B.P. Nathan, M. Orth, L.M. Dong, R.W. Mahley, and R.E. Pitas Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth J Biol Chem 270 1995 27063 27071
7. D. Benhayon, S. Magdaleno, and T. Curran Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. Brain Res Mol Brain Res 112 2003 33 45
8. G.C. Brown Nitric oxide inhibition of cytochrome oxidase and mitochondrial respiration: implications for inflammatory, neurodegenerative and ischaemic pathologies Mol Cell Biochem 174 1997 189 192
9. S. Bultel-Brienne, S. Lestavel, A. Pilon, I. Laffont, A. Tailleux, and J.C. Fruchart Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins J Biol Chem 277 2002 36092 36099
10. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J Neurochem 85 2003 1394 1401
11. M. Causevic, N. Ramoz, V. Haroutunian, K.L. Davis, and J.D. Buxbaum Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype J Neuropathol Exp Neurol 62 2003 999 1005
12. Y.R. Chen, C.L. Chen, W. Chen, J.L. Zweier, O. Augusto, and R. Radi Formation of protein tyrosine ortho-semiquinone radical and nitrotyrosine from cytochrome c-derived tyrosyl radical J Biol Chem 279 2004 18054 18062
13. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, and G.W. Small Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
14. E.H. Corder, L. Lannfelt, N. Bogdanovic, L. Fratiglioni, and H. Mori The role of APOE polymorphisms in late-onset dementias Cell Mol Life Sci 54 1998 928 934
15. M. Gearing, J.A. Schneider, R.S. Robbins, R.D. Hollister, H. Mori, and D. Games Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease J Neuropathol Exp Neurol 54 1995 833 841
16. M.B. Goldring, J.R. Birkhead, L.F. Suen, R. Yamin, S. Mizuno, and J. Glowacki Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes J Clin Invest 94 1994 2307 2316
17. J.R. Guyton, S.E. Miller, M.E. Martin, W.A. Khan, A.D. Roses, and W.J. Strittmatter Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid J Neurochem 70 1998 1235 1240
18. N. Helbecque, and P. Amouyel Very low density lipoprotein receptor in Alzheimer disease Microsc Res Tech 50 2000 273 277
19. J. Herz, and D.K. Strickland LRP: a multifunctional scavenger and signaling receptor J Clin Invest 108 2001 779 784
20. J. Herz, and H.H. Bock Lipoprotein receptors in the nervous system Annu Rev Biochem 71 2002 405 434
21. D.E. Kang, C.U. Pietrzik, L. Baum, N. Chevallier, D.E. Merriam, and M.Z. Kounnas Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway J Clin Invest 106 2000 1159 1166
22. A.D. Kay, A. Petzold, M. Kerr, G. Keir, E. Thompson, and J.A. Nicoll Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury J Neurotrauma 20 2003 943 952
23. D.H. Kim, H. Iijima, K. Goto, J. Sakai, H. Ishii, and H.J. Kim Human apolipoprotein E receptor 2 A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain J Biol Chem 271 1996 8373 8380
24. N. Komatsu, M. Yamamoto, H. Fujita, A. Miwa, K. Hatake, and T. Endo Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line UT-7 Blood 82 1993 456 464
25. B.C. Kone, T. Kuncewicz, W. Zhang, and Z.-Y. Yu Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide Am J Physiol Renal Physiol 285 2003 178 190
26. A. Law, S. Gauthier, and R. Quirion Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Rev 35 2001 73 96
27. X. Li, K. Kypreos, E.E. Zanni, and V. Zannis Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain Biochemistry 42 2003 10406 10417
28. Y. Li, M.P. Marzolo, P. van Kerkhof, G.J. Strous, and G. Bu The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low-density lipoprotein receptor-related protein J Biol Chem 275 2000 17187 17194
29. Y.J. Li, W.K. Scott, D.J. Hedges, F. Zhang, P.C. Gaskell, and M.A. Nance Age at onset in two common neurodegenerative diseases is genetically controlled Am J Hum Genet 70 2002 985 993
30. Y.J. Li, M.A. Hauser, W.K. Scott, E.R. Martin, M.W. Booze, and X.J. Qin Apolipoprotein E controls the risk and age at onset of Parkinson disease Neurology 62 2004 2005 2009
31. S.L. Ma, H.K. Ng, L. Baum, J.C. Pang, H.F. Chiu, and J. Woo Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease Neurosci Lett 332 2002 216 218
32. R.W. Mahley, and Y. Huang Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond Curr Opin Lipidol 10 1999 207 217
33. R.W. Mahley, Y. Huang, and SC. Rall Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes J Lipid Res 40 1999 1933 1949
34. M.R. Meyer, J.T. Tschanz, M.C. Norton, K.A. Welsh-Bohmer, D.C. Steffens, and B.W. Wyse APOE genotype predicts when - not whether - one is predisposed to develop Alzheimer disease Nat Genet 19 1998 321 322
35. J.V. Mulcahy, D.R. Riddell, and J.S. Owen Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux Biochem J 377 2004 741 747
36. S. Murphy Production of nitric oxide by glial cells: regulation and potential roles in the CNS Glia 29 2000 1 13
37. A.J. Myers, and A.M. Goate The genetics of late-onset Alzheimer's disease Curr Opin Neurol 14 2001 433 440
38. R.L. Nussbaum, and C.E. Ellis Alzheimer's disease and Parkinson's disease N Engl J Med 48 2003 1356 1364
39. K. Okuizumi, O. Onodera, Y. Namba, K. Ikeda, T. Yamamoto, and K. Seki Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease Nat Genet 11 1995 207 209
40. D.R. Riddell, A. Graham, and J.S. Owen Apolipoprotein E inhibits platelet aggregation through the l-arginine:nitric oxide pathway. Implications for vascular disease J Biol Chem 272 1997 89 95
41. D.R. Riddell, D.V. Vinogradov, A.K. Stannard, N. Chadwick, and J.S. Owen Identification and characterization of LRP8 (apoER2) in human blood platelets J Lipid Res 40 1999 1925 1930
42. K. Ritchie, and S. Lovestone The dementias Lancet 360 2002 1759 1766
43. S.M. Sacre, A.K. Stannard, J.S. Owen, and Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells FEBS Lett 540 2003 181 187
44. M. Sanchez-Guerra, O. Combarros, J. Infante, J. Llorca, J. Berciano, and A. Fontalba Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease Neurosci Lett 316 2001 17 20
45. M.P. Scheid, and J.R. Woodgett Unravelling the activation mechanisms of protein kinase B/Akt FEBS Lett 546 2003 108 112
46. W.J. Schneider, and J. Nimpf LDL receptor relatives at the crossroad of endocytosis and signaling Cell Mol Life Sci 60 2003 892 903
47. B.L. Scott, K. Welch, V. deSerrano, N.C. Moss, A.D. Roses, and W.J. Strittmatter Human apolipoprotein E accelerates microtubule polymerization in vitro Neurosci Lett 245 1998 105 108
48. D.L. Silver A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver J Biol Chem 277 2002 34042 34047
49. A.K. Stannard, D.R. Riddell, S.M. Sacre, A.D. Tagalakis, C. Langer, and A. von Eckardstein Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells J Biol Chem 276 2001 46011 46016
50. D.K. Strickland, S.L. Gonias, and W.S. Argraves Diverse roles for the LDL receptor family Trends Endocrinol Metab 13 2002 66 74
51. W.J. Strittmatter, A.M. Saunders, M. Goedert, K.H. Weisgraber, L.M. Dong, and R. Jakes Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease Proc Natl Acad Sci USA 91 1994 11183 11186
52. W.J. Strittmatter, and C. Bova Hill Molecular biology of apolipoprotein E Curr Opin Lipidol 13 2002 119 123
53. Y.H. Suh, and F. Checler Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease Pharmacol Rev 54 2002 469 525
54. S. Takahashi, K. Oida, M. Ookubo, J. Suzuki, M. Kohno, and T. Murase Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3 FEBS Lett 386 1996 197 200
55. B. Teter, P.T. Xu, J.R. Gilbert, A.D. Roses, D. Galasko, and G.M. Cole Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function J Neurosci Res 68 2002 331 336
56. F. Tissir, and A.M. Goffinet Reelin and brain development Nat Rev Neurosci 4 2003 496 505
57. P.G. Ulery, and D.K. Strickland LRP in Alzheimer's disease: friend or foe? J Clin Invest 106 2000 1077 1079
58. J.E. Vance, R.B. Campenot, and D.E. Vance The synthesis and transport of lipids for axonal growth and nerve regeneration Biochim Biophys Acta 1486 2000 84 96
59. J.C. Webb, D.D. Patel, M.D. Jones, B.L. Knight, and A.K. Soutar Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA Hum Mol Genet 3 1994 531 537
60. N.R. Webb, P.M. Connell, G.A. Graf, E.J. Smart, W.J. de Villiers, and F.C. de Beer SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells J Biol Chem 273 1998 15241 15248
61. K.H. Weisgraber Apolipoprotein E: structure-function relationships Adv Protein Chem 45 1994 249 302
62. K.H. Weisgraber, and R.W. Mahley Human apolipoprotein E: the Alzheimer's disease connection FASEB J 10 1996 1485 1494
63. K.H. Weiss, C. Johanssen, A. Tielsch, J. Herz, T. Deller, and M. Frotscher Malformation of the radial glial scaffold in the dentate gyrus of reeler mice, scrambler mice, and ApoER2/VLDLR-deficient mice J Comp Neurol 460 2003 56 65
64. H. Wiesinger Arginine metabolism and the synthesis of nitric oxide in the nervous system Prog Neurobiol 64 2001 365 391